Symposium 14 (open)
Is There a Crisis in New Drug Development in Child and Adolescent Psychiatry?

Thursday, October 24, 2013: 8:30 AM-11:30 AM
Flood or Trickle? The Pipeline of Medications in Development for Patients with Psychiatric Disorders
Albert John Allen, MD, PhD Eli Lilly and Company, Indianapolis, IN
Challenges in Pediatric Drug Development: The Industry Perspective
Himanshu P. Upadhyaya, MBBS, MS Eli Lilly and Company, Bellaire, TX
How Does the Food and Drug Administration Encourage Pediatric Drug Development?
Tiffany R. Farchione, MD U.S. Food and Drug Administration, Silver Spring, MD
What is the Role of National Institutes of Health and Academia in Drug Development?
Benedetto Vitiello, MD National Institute of Mental Health, Bethesda, MD

See more of: Symposium
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.